retatrutide ly3437943 triple agonist glp-1 gip glucagon mechanism GLP-3 Dosing Protocol UAE: How to Reconstitute & Dose (2026) Retatrutide—A Game Changer in Obesity

Seek support: Encourage patients to connect with support groups, friends, or family members who can help them stay motivated and accountable

The current understanding of the relationship between GLP-1/GIP agonists and retinopathy progression is based on secondary study outcomes and meta-analyses

Generally, the gastrointestinal side effects are more pronounced with shorter-acting GLP-1RA in comparison to long-acting compounds

[DOI] [PMC free article] [PubMed] [Google Scholar] 681.Ten Kulve J.S., Veltman D.J., van Bloemendaal L., Barkhof F., Drent M.L., Diamant M

DAS receives research support from Novo Nordisk and Medimmune

These medications should also be avoided in anyone with multiple endocrine neoplasia syndrome type 2 due to increased risk